We welcome you to the latest issue of EMJ Innovations! Over the past year, healthcare systems have undergone rapid transformation, demonstrating healthcare professionals’ and medical innovators’ skill and perseverance in response to the coronavirus disease (COVID-19) pandemic. Contributions in this issue reflect on the challenges from the year and highlight advancements spanning several therapeutic areas.
Latest articlesAll articles
Interview: Nassir Marrouche
EMJ is proud to present an interview with Nassir Marrouche, a globally renowned electrophysiologist and researcher currently directing a collaborative team of specialists to optimise prediction, prevention, and outcomes for cardiovascular disease (CVD) by pioneering research into digital health (DH) solutions.
Addressing Global Cancer Care Inequities Using Implementation Science and Community-Engaged Research Approaches
Worldwide, an estimated 19.3 million new cancer cases and nearly 9.9 million cancer deaths occurred in 2020. While cancer incidence rates tend to be lower in low- and middle-income countries (LMIC) compared with high-income countries (HIC), the population sizes tend to be larger, resulting in a higher absolute number of patients with cancer.
Editor's Pick: A 3D-Printed Ultrasound Task Trainer for the Practice of Hip Joint Injections
Ultrasonography is often the preferred method of imaging for needle-guided procedures of the hip joint, including aspirations, local anaesthetic injections, and the use of corticosteroids. Phantoms (i.e., training devices mimicking human tissue and bony structures under acoustic sonography) are used to help train medical professionals to perform these procedures accurately, emphasising the art of physical simulation in unison with didactic learning.
CT Colonography Versus Optical Colonoscopy: Cost-Effectiveness in Colorectal Cancer Screening
In 2017, colorectal cancer (CRC) accounted for 13% of new malignancy diagnoses in Canada. It is the second leading cause of cancer-related deaths in Canadian males, and the third leading cause of cancer related deaths in Canadian females.